技术与方法 |
|
|
|
|
易发生聚集的重组HBcAg病毒样颗粒的纯化* |
谢航航1,2,白红妹1,2,叶超1,2,陈永俊1,2,袁明翠1,2,马雁冰1,2,**() |
1 中国医学科学院北京协和医学院 医学生物学研究所 昆明 650118 2 云南省重大传染病疫苗研发重点实验室 昆明 650118 |
|
The Purification Procedure for the Recombinant HBcAg Virus-like Particle Easy to Generate Aggregation |
XIE Hang-hang1,2,BAI Hong-mei1,2,YE Chao1,2,CHEN Yong-jun1,2,YUAN Ming-cui1,2,MA Yan-bing1,2,**() |
1 Institute of Medical Biology,Chinese Academy of Medical Science&Peking Union Medical College,Kunming 650118, China 2 Yunnan Key Laboratory of Vaccine Research&Development on Severe Infectious Disease,Kunming 650118,China |
引用本文:
谢航航,白红妹,叶超,陈永俊,袁明翠,马雁冰. 易发生聚集的重组HBcAg病毒样颗粒的纯化*[J]. 中国生物工程杂志, 2020, 40(5): 40-47.
XIE Hang-hang,BAI Hong-mei,YE Chao,CHEN Yong-jun,YUAN Ming-cui,MA Yan-bing. The Purification Procedure for the Recombinant HBcAg Virus-like Particle Easy to Generate Aggregation. China Biotechnology, 2020, 40(5): 40-47.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.1912016
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I5/40
|
[1] |
Zeltins A . Construction and characterization of virus-like particles: a review. Mol Biotechnol, 2013,53(1):92-107.
|
[2] |
Birnbaum F, Nassal M . Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol, 1990,64(7):3319-3330.
|
[3] |
Chu X, Li Y, Long Q , et al. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model. Int J Nanomedicine, 2016,11:2417-2429.
|
[4] |
Long Q, Huang W, Yao Y , et al. Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation. Hum Vaccin Immunother, 2014,10(8):2303-2311.
|
[5] |
Feng X, Liu H, Chu X , et al. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer. Acta Biomater, 2019,100:316-325.
|
[6] |
黎奎, 孙鹏艳, 姚宇峰 , 等. 呈现埃博拉病毒包膜糖蛋白抗原表位重组病毒样颗粒的构建. 中国生物制品学杂志, 2017,30(4):351-356.
|
|
Li K, Sun P Y, Yao Y F , et al. Construction of recombinant virus-like particles embedding predicted antigenic epitopes of Ebola virus envolope glycoprotein. Chin J Biologicals, 2017,37(3):58-64.
|
[7] |
孙文佳, 姚宇峰, 杨旭 , 等. 乙肝核心抗原病毒样颗粒呈现HPV 16L1抗原表位及特异抗体诱导. 中国生物工程杂志, 2017,37(3):58-64.
|
|
Sun W J, Yao Y F, Yang X , et al. Presentation of HPV 16L1 peptide-based HBcAg virus-like particle and Induction of specific antibody. China Biotechnology, 2017,37(3):58-64.
|
[8] |
Chu X, Li Y, Huang W , et al. Combined immunization against TGF-beta1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artif Cells Nanomed Biotechnol, 2018,46(sup2):1199-1209.
|
[9] |
孙鹏艳 . 小鼠VEGF/FGF-2疫苗构建与肿瘤干预及埃博拉病毒样颗粒构建. 昆明:昆明医科大学, 2017.
|
|
Sun P Y . The recombinant vaccines against mouse VEGF/FGF-2 and their potentials of interventing in tumor growth in mice. Kunming:Kunming Medical University, 2017.
|
[10] |
李正丰, 王永录 . 保护剂及其在口蹄疫疫苗中的研究进展. 生物技术通报, 2009, (3):6-10.
|
|
Li Z F, Wang Y L . Study progress of the protectant in FMD vaccine. Biotechnology Bulltein, 2009, (3):6-10.
|
[11] |
Shi L, Sanyal G, Ni A , et al. Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J Pharm Sci, 2005,94(7):1538-1551.
|
[12] |
Ma Y, HayGlass K T, Becker A B , et al. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med, 2007,176(5):439-445.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|